ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
1541
Rang în acțiuni
#19247
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a biotechnology firm primarily... ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a biotechnology firm primarily dedicated to advancing immunotherapeutic treatments for various cancers. At the forefront of its development pipeline is IMM01, a CD47-targeting molecule currently undergoing clinical investigation. This lead candidate is being evaluated for its efficacy across a broad spectrum of malignancies, including myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), classical Hodgkin lymphoma (cHL), non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), head and neck squamous cell carcinomas (HNSCC), and colorectal cancer (CRC). Beyond its primary program, the company boasts a robust portfolio of experimental therapies. These comprise IMM0306, a bispecific CD47×CD20 molecule aimed at relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL); IMM2902, another bispecific agent combining CD47 and HER2 for solid tumors that are either HER2-positive or HER2-low expressing; and IMM2520, a bispecific CD47×PD-L1 molecule intended for various solid tumors. Further development efforts include IMM47, a humanized monoclonal antibody designed to target CD24 for cancer treatment; MM4701, a distinct bispecific molecule simultaneously engaging both CD47 and CD24; IMM2510, a bispecific "mAb-Trap" engineered to block both VEGF and PD-L1; IMM27M, a CTLA-4 antibody enhanced for ADCC activity; and IMM40H, a humanized IgG1 CD70 monoclonal antibody also featuring augmented ADCC activity. The company was established in 2015 and is headquartered in Shanghai, China.
Preț acțiune
$0.38122017
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$159.74M
Schimbare (1 zi)
2.58%
Schimbare (1 an)
-71.65%
Țară
CN
Tranzacționează ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541)
Categorie
Healthcare
Capitalizarea de piață a ImmuneOnco Biopharmaceuticals (Shanghai) Inc.(1541)
Capitalizare de piață: $159.74M
În anul October 2026, ImmuneOnco Biopharmaceuticals (Shanghai) Inc. are o capitalizare de piață de $159.74M. Acest lucru face ca ImmuneOnco Biopharmaceuticals (Shanghai) Inc. să fie a 19247th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a ImmuneOnco Biopharmaceuticals (Shanghai) Inc. din 2023 până în 2026
1541 în comparație cu top 5 cele mai populare stocks
| Prețul pentru 1541 | Activul B | Capitalizarea de piață a B | Rezultate | |
|---|---|---|---|---|
$12,534.39
$159.74M
|
$5.252T | +3,287,865.92% | ||
|
$11,935.22
$159.74M
|
$5.001T | +3,130,693.68% | ||
|
$9,966.12
$159.74M
|
$4.176T | +2,614,167.56% | ||
|
$9,469.52
$159.74M
|
$3.968T | +2,483,903.14% | ||
|
$6,770.56
$159.74M
|
$2.837T | +1,775,923.15% |
